The Chamber of Cosmetics Industry of the Philippines, Inc. (CCIP) recently hosted a meaningful exchange between the beauty industry and regulators during its 3rd General Membership Meeting (GMM) at the SMX Convention Center.
Held alongside the Beauty + Health & Wellness Convention, the event carried the theme “FDA Frontline: What’s New & What’s Next?”, signaling a progressive step toward open communication, transparency, and collaboration between the Food and Drug Administration (FDA) and the country’s cosmetics and personal care stakeholders.
Empowering Conversations for a Safer, Smarter Beauty Industry
This milestone gathering brought together industry professionals, entrepreneurs, and regulators for a one-of-a-kind opportunity to discuss pressing issues and future directions of the cosmetics sector.
Among the distinguished speakers were CCIP President Christine Reyes, Executive Vice President for External Affairs Janina Gutierrez-Tan (JRadiance Corporation), and FDA officers Esperanza Almenanza, Ralph Christofer Manapat, and Florlita Gabuna.
In her keynote, Reyes highlighted the importance of continuous collaboration, noting that “it’s uncommon for stakeholders to have this level of direct interaction with the FDA.” She emphasized that such dialogues build bridges that not only strengthen the industry but also uphold consumer trust and product safety.
Key Highlights from the FDA Dialogue
1. Post-Marketing Surveillance (PMS) Updates
FDA Officer Esperanza Almenanza discussed the agency’s monitoring initiatives, including how it reviews consumer complaints, conducts routine product sampling, and evaluates advertising claims.
“Brands shouldn’t fear receiving a notice of non-compliance,” Almenanza shared. “Transparency and corrective action matter most. Compliance is a shared responsibility, not a punishment.”
2. Addressing Delays and Improving Communication
The FDA acknowledged ongoing processing delays and introduced the Food and Drug Action Center (FDAC) hotline as a direct channel for follow-ups, aimed at reducing backlogs and improving communication with businesses.
3. New Guidelines for Functional Cosmetics
The agency revealed that it is drafting guidelines for Functional Pop Beauty (F-POP) products, using ASEAN standards and potentially integrating aspects of Korea’s functional cosmetics certification model.
4. Customs and Importation Clarifications
While the FDA clarified it has no direct jurisdiction over the Bureau of Customs, it continues to release public advisories to guide importers. CCIP reaffirmed its commitment to assist members navigating overlapping or unclear requirements outside FDA authority.
A Shared Vision for Progress
The meeting underscored CCIP’s vital role as the industry’s voice—strengthening the partnership between the private sector and government regulators. Through initiatives like this, the chamber continues to champion compliance as a pathway to innovation, credibility, and global competitiveness.
By fostering transparency and cooperation, CCIP and the FDA move closer to positioning the Philippines as a rising player in the international cosmetics and personal care market.
About the Chamber of Cosmetics Industry of the Philippines (CCIP)
The CCIP is a non-profit trade association representing over 180 members across the cosmetics value chain—from manufacturers and distributors to suppliers and service providers. As a founding member of the ASEAN Cosmetics Association, CCIP advocates for regulatory alignment, sustainable growth, and global competitiveness in the Philippine beauty sector.
Leave Your Comments